Enoblituzumab (MGA271) is a humanized IgG1kappa monoclonal antibody recognizing human B7-H3 protein, a member of the B7 family of immune regulators[1].
Molecular Weight:
(146.1 kDa)
Purity:
99.16
CAS Number:
[1353485-38-7]
Target:
CD276/B7-H3
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted